Medicare Enrolled

Dr. Katherine Cockerill, MD

Urology Physician · Live Oak, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
12709 TOEPPERWEIN RD STE 206, Live Oak, TX 78233
2105648000
In practice since 2015 (10 years)
NPI: 1144607805 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cockerill from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cockerill? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Cockerill

Dr. Katherine Cockerill is an urology physician in Live Oak, TX, with 10 years in practice. Based on federal Medicare data, Dr. Cockerill performed 6,236 Medicare services across 3,319 unique beneficiaries.

Between the years covered by Open Payments, Dr. Cockerill received a total of $4,687 from 27 pharmaceutical and/or device companies across 96 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Cockerill is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 10 years in practice▲ Top 17% volume in TX$ $4,687 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,236
Medicare services
Top 17% in TX for urology physician
3,319
Unique beneficiaries
$43
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~624 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Infectious disease DNA/RNA test2,066$34$78
Urinalysis with microscopic exam772$3$15
Office visit, established patient (20-29 min)728$60$150
Chronic care management, first 20 min/month338$42$81
Blood draw (venipuncture)231$8$10
Office visit, established patient (30-39 min)227$89$215
Bladder ultrasound after voiding204$7$95
PSA test (prostate cancer screening)197$18$110
Yeast/candida DNA test170$34$78
Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique170$34$78
Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique170$34$78
Diagnostic exam of bladder and urethra using an endoscope145$175$490
New patient office visit (45-59 min)128$114$313
New patient office visit (30-44 min)93$76$210
Testosterone (hormone) level, total52$25$150
Psa (prostate specific antigen) measurement, free44$18$150
Analysis for detection of tumor marker44$20$115
Hospital follow-up visit, low complexity37$38$90
Complete ultrasound scan behind abdominal cavity36$78$345
Simple insertion of temporary bladder tube32$47$180
Basic metabolic blood panel32$8$45
Simple bladder irrigation and/or instillation30$56$215
Insertion of sacral nerve neurostimulator electrode array29$298$912
Red blood cell concentration measurement24$2$8
Blood count, hemoglobin24$2$8
Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method24$140$780
Biopsy of prostate gland21$94$350
Ultrasound scan of pelvic region through rectum21$25$285
Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes20$63$165
Crushing of stone of ureter with insertion of stent using an endoscope19$302$2,000
Blood creatinine level19$5$20
Urea nitrogen level to assess kidney function, quantitative19$4$20
Insertion of stent in ureter using an endoscope16$91$1,200
Complete blood count (CBC) with differential16$8$25
Ct scan of abdomen and pelvis before and after contrast15$226$700
Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope12$552$2,600
Initial hospital admission, moderate complexity11$100$275
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.6% high complexity
5.1% medium
94.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$4,687
Total received (2018-2024)
Avg $670/year across 7 years
Top 39% in TX for urology physician
27
Companies
96
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,687 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$612
2023
$484
2022
$570
2021
$289
2020
$1,038
2019
$764
2018
$930

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Medtronic USA, Inc.
$1,039
Medtronic, Inc.
$529
Coloplast Corp
$453
Boston Scientific Corporation
$367
Astellas Pharma US Inc
$320
Axonics, Inc.
$198
ABBVIE INC.
$170
Janssen Biotech, Inc.
$156
Intuitive Surgical, Inc.
$149
Calyxo, Inc.
$142
KARL STORZ Endoscopy-America
$141
Olympus America Inc.
$129
C. R. Bard, Inc. & Subsidiaries
$126
CONMED Corporation
$123
Ferring Pharmaceuticals Inc.
$122
AbbVie Inc.
$118
PFIZER INC.
$99
C. R. BARD, INC. & SUBSIDIARIES
$77
Sumitomo Pharma America, Inc.
$60
Stryker Corporation
$32
Novartis Pharmaceuticals Corporation
$24
Myovant Sciences Inc.
$22
Supernus Pharmaceuticals, Inc.
$19
TOLMAR Pharmaceuticals, Inc.
$18
UROVANT SCIENCES INC
$18
Allergan, Inc.
$18
Verity Pharmaceuticals Inc.
$17
Top 3 companies account for 43.1% of total payments
Associated products mentioned in payments ›
8.5 FR. X 675MM · AIRSEAL · Altis · Axonics · Axonics r-SNM System · BOTOX · CLARIFIX CRYOTHERAPY DEVICE · CMOS VIDEO URETEROSCOPE · CVAC ASPIRATION SYSTEM · Da Vinci Surgical System · ELIGARD · ENDOBEAM · ERLEADA · FIRMAGON · GEMTESA · INTERSTIM · LITHOVUE · LYNX · Lumenis Pulse 120H · MYRBETRIQ · Myrbetriq · NURO · ORGOVYX · Olympus Laser Devices · PLUVICTO · TITAN · TLANDO · Trelstar · XTANDI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $75 per 100 Medicare services performed
Looking for a urology physician in Live Oak?
Compare urology physicians in the Live Oak area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology Physicians within 10 mi
103
Per 100K population
5.1
County median income
$70,571
Nearest hospital
LAUREL RIDGE TREATMENT CENTER
5.9 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Cockerill is a clinical cardiology specialist, with above-average Medicare volume (top 17% in TX), and low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Cockerill experienced with infectious disease dna/rna test?
Based on Medicare claims data, Dr. Cockerill performed 2,066 infectious disease dna/rna test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cockerill receive payments from pharmaceutical companies?
Yes. Dr. Cockerill received a total of $4,687 from 27 companies across 96 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cockerill's costs compare to other urology physicians in Live Oak?
Dr. Cockerill's average Medicare payment per service is $43. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cockerill) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →